Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

Hair loss is common in IBD patients, and some medications may lower the risk.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Dermoscopy can help diagnose tinea capitis in children by looking for comma hairs, black dots, and broken hairs with white bands.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

New therapies are being developed that target integrin pathways to treat various diseases.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Effective treatments for severe alopecia areata are still lacking.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.